In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Late-Breaking Science: Are outcomes different for men and women after early-onset MI?

In general, women with myocardial infarction (MI) tend to present at a later age with a greater risk factor burden and varied symptoms compared with men, and thus have worse outcomes. Few studies have investigated differences in outcomes between premenopausal females and men with early-onset MI, until today’s Late-Breaking Science presentation by Professor Diego Ardissino (Parma University Hospital, Italy).

Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
Cardiovascular Disease in Special Populations

As part of the Italian Genetic Study on Early-onset Myocardial Infarction, data from 1,778 men and 222 women aged less than 45 years who presented with an MI at one of 125 Italian coronary care units (1998–2002) were analysed. During a median follow-up of 20 years, the primary endpoint of recurrent non-fatal MI, stroke or cardiovascular death occurred in 25.7% of women compared with 37.0% of men (hazard ratio [HR] 0.69; 95% confidence interval [CI] 0.52–0.91; p=0.01). When the components of the primary endpoint were analysed separately, recurrent MI was less frequent in women vs. men (14.2% vs. 25.4%; HR 0.53; 95% CI 0.37–0.77; p<0.001). However, women were more likely to have a stroke compared with men (7.7% vs. 3.7%; HR 2.02; 95% CI 1.17–3.49; p=0.012). Women were more than twice as likely to have normal or non­significant coronary artery stenoses at the time of angiography than men (36.5% vs. 15.4%; p<0.001), but coronary artery dissection was more frequent in women (5.4% vs. 0.7%; p<0.01).

More men than women had cardiovascular risk factors, including smoking (46.5% vs. 42.8%), alcohol consumption (65.3% vs. 27.4%), dyslipidaemia (62.3% vs. 50.7%) and diabetes (7.8% vs. 5.4%) (all p<0.001). Although statin prescription at discharge was similar in men and women, men were more likely to be prescribed beta-blockers, aspirin and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. The disparity in prescribing may be due to the lower burden of coronary artery disease found in women in the study. It could also relate to the general under-prescribing of medication for women compared with men as seen in other studies of acute cardiac events.

Prof. Ardissino concluded, “In contrast to the prevailing literature for MI in general, premenopausal women experiencing early-onset MI have favourable long-term outcomes compared with men, despite being prescribed fewer preventive medications.” Distinct mechanisms of cardiovascular disease and the protective effect of oestrogen may be responsible for these differences.

The content of this article reflects the personal opinion of the author/s and is not necessarily the official position of the European Society of Cardiology.